Last updated: 2026-10-07 22:30:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Iridex Corp. (IRIX) operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0,86, with a market capitalisation of $12,12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,61 to $1,65. This page covers its latest market performance, valuation, price trends and company information.
$12,12M | |
$0,69 | |
$16,64 | |
$0,36 | |
$0,68 | |
12,59M | |
71,25K | |
-- | |
$1,65 | |
$0,61 | |
-- | |
-- |
Iridex Corp. (IRIX) is trading at $0,85 in after-hours trading as of 2026-10-07 22:29:00, up 25,59% ($0,17) from the regular-session close of $0,68.
After-hours trading shows how investors are pricing IRIX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Iridex Corp. (IRIX) moved from $0,62 to $0,86, representing a gain of 38,85% ($0,24).
The stock traded between $0,62 and $0,99 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 49,40 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 24,4%
IRIX is currently trading at $0,86, placing it 24,4% of the way from its 52-week low of $0,61 to its 52-week high of $1,65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
| Industry | ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS |
| Employees | 108 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Iridex Corp. (IRIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.